Previous studies have reported that Irf4 restricts chronic kidney disease progression and kidney fibrosis following ischemia reperfusion injury, potentially by enabling M2 macrophage polarization and suppressing a Th1 cytokine response [46]. Here, IRF4 is linked to chronic kidney disease.